...
首页> 外文期刊>Frontiers in Oncology >Immune Modulation in HLA-G Expressing Head and Neck Squamous Cell Carcinoma in Relation to Human Papilloma Virus Positivity: A Study From Northeast India
【24h】

Immune Modulation in HLA-G Expressing Head and Neck Squamous Cell Carcinoma in Relation to Human Papilloma Virus Positivity: A Study From Northeast India

机译:HLA-G表达头部和颈部鳞状细胞癌的免疫调节与人乳头瘤病毒阳性有关:印度东北部的研究

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background: Tumor specific ectopic expression of the immunomodulatory molecule, HLA-G is known to mediate immune tolerance and promote carcinogenesis. Viruses too employ strategies to evade immune surveillance. Considering the role of both HLA-G and HPV in tumor growth and progression, it is pertinent to investigate the relationship between HLA-G and HPV in context of immune modulation in HNSCC. Method: A hospital based case–control study was conducted in histopathologically confirmed HNSCC tissues. HLA-G isoform expression and HPV association studies were carried out and mRNA levels of HLA-G, markers of proliferation and differentiation (ki-67, keratin 18, cyclin D1), immune checkpoint molecules (IL-10, PD-1. TGF-β), SOCS (SOCS1 and SOCS3) and pro-inflammatory cytokine IFN-γ were determined. Results: Higher expression of HLA-G was noted in HPV positive tumors (5.14 fold, p = 0.002). HLA-G7 was the most frequent isoform (29/80) found in HNSCC particularly in HPV positive tumors (13/16). In HPV negative tumors, all the checkpoint molecules were upregulated along with pro–inflammatory IFN-γ. In contrast, in HPV positive tumors, IFN-γ expression was higher (2.12 fold) but levels of IL-10, PD-1, TGF-β, SOCS1 and SOCS3 were markedly lower (fold change of IL-10 = 0.37, PD1 = 0.41, TGF-β = 0.17, SOCS1 = 0.055, SOCS3 = 0.027). HPV positive tumors were more proliferative and differentiated with higher expression of ki-67 and keratin18 (6.25 fold, p = 0.079 and 10.62 fold, p = 0.009). Decreased expression of cyclin D1 was noted in HPV positive tumors (6.94 fold, p = 0.006) than HPV negative tumors (17.69 fold). Also, HLA-G7 expressing HPV positive tumors showed lowest expression of cyclin D1. Interestingly, SOCS showed normal expression in HLA-G7 expressing HPV negative tumors (1.2 and 1.4 fold). IFN-γ was downregulated in HPV positive tumors without HLA-G7 (0.31 fold). Conclusion: Our data suggests that SOCS were downregulated irrespective of HLA-G positivity and IFN- γ expression appeared to be mediated by HLA-G. SOCS are reported to have anti-tumor activity and also SOCS and soluble HLA-G are known to interfere with cell cycle progression. Hence, through regulating HLA-G expression, HPV positive tumors could mediate immune suppression by manipulating SOCS, IFN-γ, IL-10 and cyclin D1 pathways which needs further exploration.
机译:背景:肿瘤特异性异位表达免疫调节分子,已知HLA-G用于介导免疫耐受性和促进致癌作用。病毒也使用逃避免疫监测的策略。考虑到HLA-G和HPV在肿瘤生长和进展中的作用,它有关研究HLA-G和HPV在HNSCC中免疫调节背景下的关系。方法:在组织病理学证实的HNSCC组织中进行了基于医院的案例对照研究。进行HLA-G同种型表达和HPV关联研究和HLA-G的mRNA水平,增殖和分化的标志物(Ki-67,角蛋白18,细胞周期蛋白D1),免疫检查点分子(IL-10,PD-1。TGF -β),测定SOCS(SOCS1和SOCS3)和促炎细胞因子IFN-γ。结果:HPV阳性肿瘤中较高的HLA-G表达(5.14折,P = 0.002)。 HLA-G7是HNSCC中最常见的同种型(29/80),特别是HPV阳性肿瘤(13/16)。在HPV阴性肿瘤中,将所有检查点分子与促炎IFN-γ一起上调。相比之下,在HPV阳性肿瘤中,IFN-γ表达较高(2.12倍),但IL-10,PD-1,TGF-β,SOCS1和SOCS3的水平显着降低(IL-10的折叠变化= 0.37,PD1 = 0.41,TGF-β= 0.17,SOCS1 = 0.055,SOCS3 = 0.027)。 HPV阳性肿瘤更增殖并与ki-67和角蛋白的表达更高(6.25倍,p = 0.079和10.62折,p = 0.009)。在HPV阳性肿瘤(6.94倍,P = 0.006)中,对细胞周期蛋白D1的表达降低而不是HPV阴性肿瘤(17.69倍)。此外,表达HPV阳性肿瘤的HLA-G7显示出细胞周期蛋白D1的最低表达。有趣的是,SOC在表达HPV阴性肿瘤(1.2和1.4倍)的HLA-G7中显示正常表达。 IFN-γ在没有HLA-G7的HPV阳性肿瘤中下调(0.31倍)。结论:我们的数据表明,无论HLA-g积极性如何,SOC都是下调,并且IFN-γ表达似乎由HLA-G介导。据报道,SOC具有抗肿瘤活性,并且已知SOC和可溶性HLA-G干扰细胞周期进展。因此,通过调节HLA-G表达,HPV阳性肿瘤可通过操纵需要进一步探索的SOC,IFN-γ,IL-10和Cyclin D1途径介导免疫抑制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号